COVID-19

The FDA on Sunday issued an emergency use authorization to allow treatment with COVID-19 convalescent plasma for patients who are hospitalized with the disease.

Pandemic is disrupting clinical facilities, putting individuals’ ocular health at risk

Michael X. Repka, MD, vice chair of clinical practice at Wilmer Eye Institute (Johns Hopkins University) speaks on the institution's latest protocol changes allowing for the resumption of elective surgery as well as the adaptations clinicians have had to make in order to ensure the continuation of clinical practice at Wilmer Eye Institute.

Ophthalmologists share what keeps them up at night in the ophthalmic profession amid the pandemic.

Summer is typically a busy and spirited season for ophthalmology match candidates. Medical students endeavor to build a personal brand, draft their personal statements, update their curriculum vitae, and secure letters of recommendation in preparation for their ophthalmology residency applications.

In this second installment, ophthalmologists share how their expectations for "the year of the eye" have compared and contrasted to reality amid the global pandemic.

Investigators conducted a slit lamp biomicroscope experiment, simulating a patient undergoing an eye examination and then spontaneously coughing, spraying droplets.

Ophthalmologists share their outlook for the current state and future of the ophthalmic profession, how coronavirus pandemic has altered the profession as well as how —now, more than ever — patient care remains a number one priority for ophthalmologists.

One ophthalmologist offers insight on how to help patients treat their dry eye symptoms when working from home amid the pandemic.

Despite current flexibility, future enforcement could prove to be troublesome

The use of a human monoclonal antibody (Narsoplimab, Omeros) to treat acute respiratory distress syndrome (ARDS) associated with COVID-19 resulted in recovery and survival of the affected patients.

According to a recent study, communities across the country are dealing with an increased number of mental health challenges due to “COVID-19–associated morbidity, mortality, and mitigation activities.”

Retina specialists Caesar Luo, MD, of Bay Area Retina Associates (Walnut Creek, CA) and S.K. Steven Houston III, MD, of Florida Retina Institute, share their outlooks on retina innovation in the "year of the eye" amid a global pandemic.

To prepare students and their families for the new school year, the American Academy of Ophthalmology is sharing a back-to-online school checklist to help prevent digital eye strain.

COVID-19 pandemic is accelerating cultural paradigm shift for medical professionals

Researchers note that more study of conjunctivitis is needed in patients with COVID-19

A team of Turkish investigators detected COVID-19 viral material on the environmental surfaces of an ophthalmology examination room despite triage systems to exclude patients with the virus.

An ophthalmologist details how the COVID-19 crisis has helped him focus on essentials

S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon, and adapting to ever-changing operating room spacing and set-up in the COVID-19 environment

An inhaled formulation of interferon beta, significantly decreased the chances of hospitalized patients developing severe COVID-19 compared to placebo.

According to a study presented at the American Society of Ophthalmic Trauma conference, patients are experiencing domestic injuries, delaying care, traveling for care, and have less insurance.

The Department of Health and Human Services recently extended the national public health emergency declared for the COVID-19 pandemic, thereby extending payment and regulatory flexibilities. Amid the pandemic, ophthalmologists continue to adapt to practicing in the era of COVID-19.

The COVID-19 global pandemic continues to have an impact on ophthalmologists, their practices and daily life. For patients, there can be additional pressures that are concerning.

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye

About 10.1 million people could lose employer-based insurance coverage this year as a result of the Covid-19 pandemic, according to a report released by the Robert Wood Johnson Foundation.